Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

2.

Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.

Bate C, Williams A.

J Biol Chem. 2011 Mar 18;286(11):8752-8. doi: 10.1074/jbc.M110.186833. Epub 2011 Jan 6.

3.

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.

Bate C, Tayebi M, Diomede L, Salmona M, Williams A.

BMC Biol. 2008 Sep 12;6:39. doi: 10.1186/1741-7007-6-39.

4.

Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.

Bate C, Tayebi M, Williams A.

J Biol Chem. 2010 Jul 16;285(29):22017-26. doi: 10.1074/jbc.M110.108548. Epub 2010 Apr 28.

5.

The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.

Bate C, Tayebi M, Williams A.

Biochem J. 2010 Apr 28;428(1):95-101. doi: 10.1042/BJ20091469.

PMID:
20196773
6.
7.

Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.

Bate C, Nolan W, Williams A.

J Biol Chem. 2016 Jan 1;291(1):160-70. doi: 10.1074/jbc.M115.672394. Epub 2015 Nov 9.

8.

Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.

Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB.

J Cell Biol. 1995 Apr;129(1):121-32. Erratum in: J Cell Biol 1995 Jul;130(2):501. Avraham D [corrected to Avrahami D].

9.
10.

A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.

Bate C, Tayebi M, Williams A.

Neuropharmacology. 2010 Jul-Aug;59(1-2):93-9. doi: 10.1016/j.neuropharm.2010.04.002. Epub 2010 Apr 14.

PMID:
20398681
12.

The prion protein requires cholesterol for cell surface localization.

Gilch S, Kehler C, Schätzl HM.

Mol Cell Neurosci. 2006 Feb;31(2):346-53. Epub 2005 Nov 8.

PMID:
16278084
13.

Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.

Bate C, Tayebi M, Diomede L, Salmona M, Williams A.

PLoS One. 2009 Dec 9;4(12):e8221. doi: 10.1371/journal.pone.0008221.

14.

Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.

West E, Osborne C, Nolan W, Bate C.

Biology (Basel). 2015 Jun 2;4(2):367-82. doi: 10.3390/biology4020367.

15.

Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.

Taylor DR, Whitehouse IJ, Hooper NM.

PLoS Pathog. 2009 Nov;5(11):e1000666. doi: 10.1371/journal.ppat.1000666. Epub 2009 Nov 20.

16.

PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.

Marshall KE, Hughson A, Vascellari S, Priola SA, Sakudo A, Onodera T, Baron GS.

J Virol. 2017 Jan 3;91(2). pii: e01686-16. doi: 10.1128/JVI.01686-16. Print 2017 Jan 15.

17.

The role of rafts in the fibrillization and aggregation of prions.

Pinheiro TJ.

Chem Phys Lipids. 2006 Jun;141(1-2):66-71. Epub 2006 Mar 27. Review.

PMID:
16647049
18.

Translocation of cellular prion protein to non-lipid rafts protects human prion-mediated neuronal damage.

Jeong JK, Moon MH, Lee YJ, Seol JW, Park SY.

Int J Mol Med. 2012 Mar;29(3):387-92. doi: 10.3892/ijmm.2011.864. Epub 2011 Dec 15.

PMID:
22179431
19.

Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.

Bate C, Nolan W, Williams A.

Prion. 2016 Mar 3;10(2):127-30. doi: 10.1080/19336896.2016.1148237.

20.

Binding of prion proteins to lipid membranes.

Critchley P, Kazlauskaite J, Eason R, Pinheiro TJ.

Biochem Biophys Res Commun. 2004 Jan 16;313(3):559-67.

PMID:
14697227

Supplemental Content

Support Center